Evidence map›Paper›PMID 30127130›Full record

ArticleNeural regeneration research2018

The novel chalcone analog L2H17 protects retinal ganglion cells from oxidative stress-induced apoptosis.

Lei Wang, Huai-Cheng Chen, Xi Yang, Jian-Jian Tao, Guang Liang, Jian-Zhang Wu, Wen-Can Wu, Yi Wang, Zong-Ming Song, Xin Zhang

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Glaucoma: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lei WangChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Huai-Cheng ChenChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Xi YangChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Jian-Jian TaoChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Guang LiangChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Jian-Zhang WuChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Wen-Can WuThe Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Yi WangChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Zong-Ming SongThe Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Xin ZhangChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Wenzhou Medical University · CNAffiliated Eye Hospital of Wenzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chalcone is a plant metabolite widely found in fruits, vegetables, spices and tea, and has anti-tumor, anti-inflammation, immunomodulation, antibacterial and anti-oxidation activities, as well as many other pharmacological and biological effects. Our team has shown that its analogs have antioxidant activity, and oxidative stress is a pathological hallmark of retinal ischemia/reperfusion injury that can lead to retinal damage and visual loss. This investigation aims to identify a chalcone that protects retinal ganglion cells in vitro from the effects of oxidative stress and examine its mechanism. Rat retinal ganglion cell-5 cells were pretreated with chalcones and then exposed to tert-butyl hydroperoxide that causes oxidative damage. Controls received dimethyl sulfoxide only or tert-butyl hydroperoxide in dimethyl sulfoxide. Only (E)-3,4-dihydroxy-2'-methylether ketone (L2H17), of the five chalcone analogs, markedly increased the survival rate of oxidatively injured RGC-5 cells. Thus, subsequent experiments only analyzed the results of the L2H17 intervention. Cell viability and apoptosis were measured. Intracellular superoxide dismutase and reactive oxygen species levels were used to assess induced oxidative stress. The mechanism of action by L2H17 was explored by measuring the ER stress/UPR pathway and the expression and localization of Nrf2. All results demonstrated that L2H17 could reduce the apoptosis of oxidatively injured cells, inhibit caspase-3 activity, increase Bcl-2 expression, decrease Bad expression, increase the activity of superoxide dismutase, inhibit the production of reactive oxygen species, increase Nrf2 immunoreactivity, and reduce the activating transcription factor 4, phospho-eukaryotic initiation factor 2 and CHOP expression. L2H17 protects retinal ganglion cells induced by oxidative stress by regulating Nrf2, which indicates that it has the potential to become a drug for retinal ischemia/reperfusion.

Indexed as

apoptosischalcone analogsendoplasmic reticulum stressnerve regenerationneural regenerationnuclear erythroid-related factor-2oxidative stressreactive oxygen speciesretinal ganglion cellsretinal ischemia/reperfusion injury

Identifiers

PMID30127130
PMCPMC6126127
OpenAlexW2887200121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.